Tim Baker

Explain It to Me Please

Business EN ↓ 196 episodes

Breaking down business strategies and financial reports of companies I follow. Not financial advise, not investment advise, AI audio analysis from AI-generated financial reports looking at the latest financial reports from SEC filings, investor relations content, management comments, analyst reports and business and industry publications that are publicly available..

Author

Tim Baker

Category

Business

Podcast website

rss.com

Latest episode

Jul 10, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

2026Q2 Cisco Systems Inc. (CSCO) 18.02.2026

Cisco Systems, Inc. (CSCO) stands at the precipice of its most significant transformation since the dot-com era. As the undisputed architect of the internet’s plumbing for nearly four decades, Cisco is now navigating a complex pivot from a hardware-centric networking vendor to a recurring-revenue software and services powerhouse, all while attempting to capture a leading position in the nascent bu...

2025Q4 Boston Scientific Corporation (BSX) 18.02.2026

Boston Scientific Corporation (NYSE: BSX) enters the 2026 fiscal year at a pivotal inflection point, characterized by a stark divergence between its operational fundamentals and market sentiment. Having successfully concluded fiscal year 2025 with $20.07 billion in net sales—a milestone reflecting a 19.9% reported growth rate 1—the company has firmly established itself as a high-growth outlier wit...

2025Q4 Shopify Inc. (SHOP) 17.02.2026

As of February 2026, Shopify Inc. stands at a defining juncture in its corporate evolution, marking the successful transition from a high-velocity pandemic beneficiary to a disciplined, diversified enterprise software juggernaut. The fiscal year 2025 results, delivered on February 11, 2026, serve as a validation of the company's strategic recalibration following the divestiture of its logistics ar...

2025Q4 Palantir Technologies Inc. (PLTR) 17.02.2026

As of February 17, 2026, Palantir Technologies (PLTR) occupies a singular position in the global software landscape. Having transcended its origins as a secretive defense contractor, the company has successfully operationalized the deployment of artificial intelligence at an enterprise scale, creating a financial profile that defies the gravitational pull currently affecting the broader Software-a...

2025Q4 Cameco Corporation (CCJ) 17.02.2026

Cameco Corporation (CCJ) sits at the epicenter of a tripartite global structural shift: the imperative for decarbonization, the unprecedented energy intensity of the Artificial Intelligence (AI) revolution, and the urgent geopolitical necessity to secure energy supply chains independent of Russian influence. As of February 2026, Cameco has transcended its traditional categorization as a mere commo...

2025Q4 Mastercard Incorporated (MA) 15.02.2026

Mastercard Incorporated (NYSE: MA) concludes its Fiscal Year 2025 at a strategic inflection point, demonstrating robust financial resilience in a macroeconomic environment characterized by stabilizing inflation, shifting monetary policy, and heightened regulatory scrutiny. As of February 15, 2026, the company continues to assert its dominance within the global payments duopoly, reporting full-year...

2025Q4 Freeport-McMoRan Inc. (FCX) 15.02.2026

As of February 15, 2026, Freeport-McMoRan Inc. (FCX) presents a compelling, albeit complex, investment case defined by the tension between short-term operational volatility and a secular demand super-cycle of unprecedented magnitude. Trading at approximately $62.84, the equity reflects a market grappling with the immediate fallout of the September 2025 geotechnical incident at the Grasberg Mineral...

2026Q2 AEHR Test Systems (AEHR) 14.02.2026

Aehr Test Systems (AEHR) finds itself at a defining inflection point in February 2026, creating a complex risk-reward profile that demands rigorous dissection. Historically recognized for its dominance in the Silicon Carbide (SiC) burn-in market—essential for the burgeoning electric vehicle (EV) sector—the company is currently executing a high-stakes strategic pivot toward Artificial Intelligence...

2026Q1 Apple Inc. (AAPL) 14.02.2026

Apple Inc. (AAPL) stands at a pivotal juncture in its corporate history, transitioning from a hardware-centric consumer electronics manufacturer into a fully integrated digital services and artificial intelligence conglomerate. The fiscal first quarter of 2026 (ended December 27, 2025) serves as a definitive validation of the company's "AI Supercycle" strategy. With record-breaking revenue of $143...

2025Q4 Amazon.com Inc. (AMZN) 14.02.2026

On February 5, 2026, Amazon.com Inc. delivered a financial disclosure that will likely be remembered as a watershed moment in the history of the technology sector.1 While the company reported robust fourth-quarter results—with net sales accelerating 14% year-over-year to $213.4 billion and Amazon Web Services (AWS) revenue growing at its fastest clip in three years—the narrative was entirely subsu...

2025Q4 Alphabet Inc. (GOOGL) 14.02.2026

Alphabet Inc. enters 2026 at a defining inflection point in its corporate history. The release of the Fourth Quarter and Full Year 2025 results on February 4, 2026, has fundamentally altered the investment narrative surrounding the company. No longer viewed solely as a mature digital advertising utility, Alphabet has aggressively repositioned itself as a capital-intensive infrastructure behemoth,...

2025Q4 Advanced Micro Devices, Inc. (AMD) 14.02.2026

As of February 4, 2026, Advanced Micro Devices, Inc. (AMD) stands at a defining juncture in its corporate history. The company has successfully navigated a multi-year transformation from a second-tier PC component manufacturer into a duopolistic power within the high-performance computing (HPC) and artificial intelligence (AI) infrastructure market. The release of the Fiscal Year 2025 and Q4 2025...

2025Q4 Medpace Holdings, Inc. (MEDP) 13.02.2026

Medpace Holdings, Inc. (NASDAQ: MEDP) operates as a scientifically-driven, global, full-service clinical Contract Research Organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. Unlike its larger peers who often rely on functional service provider (FSP) models or massive data commercialization arms, Medpace has ste...

2025Q4 Unity Software Inc. (U) 13.02.2026

As of February 2026, Unity Software Inc. (U) presents a complex investment case defined by a rigorous operational turnaround colliding with a hostile macroeconomic environment. The company has successfully navigated the immediate aftermath of its 2023 operational crisis, executing a decisive "portfolio reset" under CEO Matthew Bromberg that has stabilized the balance sheet and restored core profit...

2025Q4 Stryker Corporation (SYK) 13.02.2026

1.1 The Stryker Proposition: Resilience in a Volatile Era Stryker Corporation enters the 2026 fiscal year as a paradigm of operational excellence within the global medical technology sector, distinguished by its relentless organic growth profile and strategic capital deployment. Having concluded Fiscal Year 2025 with record-breaking revenues exceeding $25.1 billion and adjusted earnings per share...

2025Q4 Corning Incorporated (GLW) 13.02.2026

As of mid-February 2026, Corning Incorporated (GLW) has fundamentally successfully transitioned from a cyclical industrial manufacturer into a critical infrastructure cornerstone for the Generative Artificial Intelligence (GenAI) era. The company’s Fourth Quarter and Full-Year 2025 results, released on January 28, 2026, served as a definitive validation of its "Springboard" framework—a strategic p...

2025Q4 Eli Lily and Lilly and Company (LLY) 13.02.2026

Eli Lilly and Company (LLY) has redefined the boundaries of the pharmaceutical industry, emerging as the first healthcare entity to surpass a $1 trillion market capitalization. As of February 2026, the company stands at the vanguard of a metabolic revolution, driven by its incretin-based therapies, Mounjaro (tirzepatide) for type 2 diabetes and Zepbound (tirzepatide) for obesity. The fiscal year 2...

2025Q4 Bristol-Myers Squibb Company (BMY) 13.02.2026

As of mid-February 2026, Bristol-Myers Squibb (BMY) represents one of the most complex investment narratives in the large-cap pharmaceutical sector. The company is currently executing a high-stakes pivot, characterized by a bifurcation of its asset base: a rapidly expanding "Growth Portfolio" that now constitutes nearly 60% of total revenue, battling against the accelerated erosion of a massive "L...

2025Q4 Crispr Theraputics AG (CRSP) 13.02.2026

CRISPR Therapeutics AG (CRSP) stands at a pivotal juncture in the history of biotechnology as it navigates the transition from a clinical-stage pioneer to a commercial-stage entity. As the co-developer of CASGEVY™ (exagamglogene autotemcel), the world’s first approved therapy utilizing the Nobel Prize-winning CRISPR/Cas9 technology, the company has validated its platform. However, the fiscal year...

2025Q4 Albemarle Corporation (ALB) 13.02.2026

As of mid-February 2026, Albemarle Corporation (ALB) finds itself at the nexus of a profound structural transformation within the global energy storage market. The company’s Fourth Quarter and Full-Year 2025 results, released on February 12, 2026, delineate a year characterized by extreme price volatility, aggressive portfolio rationalization, and a decisive pivot from capital-intensive expansion...

2025Q4 Bloom Energy Corp (BE) 13.02.2026

Bloom Energy Corporation (NYSE: BE) has reached a pivotal inflection point in its corporate history as of early 2026. Once viewed primarily as a niche provider of distributed energy resources (DER) for sustainability-focused corporations, the company has successfully repositioned itself as a critical infrastructure enabler for the Artificial Intelligence (AI) and data center economy. The fiscal ye...

Listen to the Explain It to Me Please podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.